Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AMGN | GILD | BIIB | CELG |
| Company | Ascendis Pharma ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 135.16 | 301.75 | 65.43 | 221.52 | 108.01 |
| High | 137.65 | 302.91 | 66.14 | 221.98 | 108.59 |
| Low | 134.50 | 298.51 | 65.16 | 216.08 | 107.27 |
| Last | 135.98 | 300.30 | 65.46 | 218.92 | 108.24 |
| Change | +1.98 | +0.82 | -0.08 | -2.50 | +0.11 |
| % Change | +1.48% | +0.27% | -0.12% | -1.13% | +0.10% |
| Volume | 504,586 | 2,451,925 | 7,240,200 | 1,156,371 | 191,230,496 |
| 20-Day Average Volume | 336,494 | 2,824,191 | 7,601,965 | 1,377,414 | 16,188,930 |
| Previous Close | 134.00 | 299.48 | 65.54 | 221.42 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 141.52 | 275.28 | 66.46 | 204.54 | 108.17 |
| 20-Day Raw Stochastic | 11.05% | 63.99% | 20.81% | 89.44% | 63.25% |
| 20-Day Relative Strength | 42.65% | 63.04% | 34.46% | 56.77% | 64.69% |
| Weighted Alpha | +43.87 | +28.12 | -20.14 | -27.18 | +46.30 |
| Today's Opinion | 24% Buy | 40% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 24% Buy | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.78% since 04/30/24 | +9.62% since 04/30/24 | +0.40% since 04/30/24 | +1.91% since 04/30/24 | -1.97% since 11/13/19 |
| Low | 133.53 on 05/06/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 213.11 on 05/03/24 | 107.27 on 11/20/19 |
| High | 143.99 on 05/02/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 222.40 on 05/06/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -9.27% since 04/05/24 | +11.24% since 04/05/24 | -5.92% since 04/05/24 | +7.38% since 04/05/24 | +5.14% since 10/18/19 |
| Low | 133.39 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 156.84 on 04/10/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 222.40 on 05/06/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -2.38% since 02/07/24 | +1.50% since 02/07/24 | -12.04% since 02/07/24 | -8.99% since 02/07/24 | +13.63% since 08/20/19 |
| Low | 133.39 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 161.00 on 02/26/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 244.95 on 02/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +41.42% since 11/07/23 | +10.77% since 11/07/23 | -18.79% since 11/07/23 | -10.87% since 11/07/23 | +14.14% since 05/20/19 |
| Low | 86.54 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 161.00 on 02/26/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,802,015 | 160,633,888 | 81,602,352 | 32,238,088 | 77,035,920 |
| Shares Outstanding, K | 58,224 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 288,670,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -521,070,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 104,110,000 | 7,447,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | -142,260,000 | -113,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 0.54 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 14.50 | 10.99 |